CHICAGO — Amgen’s month-to-month weight problems candidate led to substantial weight reduction however a excessive charge of unintended effects and…
Read More
Amgen loses $400 million antitrust battle to Regeneron
Need to keep on high of the science and politics driving biotech at the moment? Join to get our biotech…
Read More
